HOME >> BIOLOGY >> NEWS
RNA interference methods highlighted in Cold Spring Harbor Protocols

Cold Spring Harbor, N.Y., Tues., Aug. 1, 2006 The current issue of Cold Spring Harbor Protocols, published online today, features new, freely available methods for using RNA interference (RNAi) in mice and Drosophila. RNAi is a technique that allows researchers to specifically block the action of individual genes without affecting the expression of others. These protocols--contributed by leading scientists in the RNAi field--will be useful to many researchers seeking to identify the biological functions of genes in important biological model systems.

Among the more than 50 new methods published today are protocols for handling embryonic stem cells, visualizing events leading to programmed cell death, and preparing cells and proteins for microscopic imaging. The latest issue adds greater depth to the substantial archive of protocols that has been available since the launch of this new scientific resource in May of 2006.


'"/>

Contact: Maria Smit
smit@cshl.edu
516-422-4127
Cold Spring Harbor Laboratory
2-Aug-2006


Page: 1

Related biology news :

1. Cocaine high caused by interference in neuronal receiving stations
2. 454 Sequencing reveals new pathway in RNA interference
3. Scientists identify genetic pathways essential to RNA interference
4. Silence the gene, save the cell: RNA interference as promising therapy for ALS
5. S1P1 essential for tumor growth and is blocked by RNA interference
6. Bioinformatics-related methods are featured in Cold Spring Harbor Protocols
7. Rutgers, Penn researchers capture research dollars to improve prostate cancer diagnostic methods
8. Cold Spring Harbor Protocols features methods to understand embryos, clones, stem cells
9. A rainbow of methods promises insights into biological processes and diseases
10. New methods and tools needed to measure exposure to airborne nanomaterials
11. Cold Spring Harbor Protocols highlights reliable methods for gene and protein analyses

Post Your Comments:
(Date:7/24/2014)... is available in German . ... 300 million asthma sufferers worldwide, a further 600 million ... of the global population contending with allergic rhinitis (allergic ... also affect other organs and parts of the body ... intestine (in the form of inflammatory bowel diseases such ...
(Date:7/24/2014)... is available in German . ... recognize and respond to threats to health, and to ... understanding of the mechanism underlying immunologic memory, however, has ... converged to support the hypothesis that the persistence of ... with stem-cell-like potential. Until now, there was no conclusive ...
(Date:7/23/2014)... of identical twins has found that early reading skill ... the journal Child Development , was conducted by ... London. , "Since reading is an ability that can ... according to Stuart J. Ritchie, research fellow in psychology ... "Early remediation of reading problems might aid not only ...
Breaking Biology News(10 mins):New drugs to combat asthma and the like 2New drugs to combat asthma and the like 3Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3Stronger early reading skills predict higher intelligence later 2
(Date:7/24/2014)... July 24, 2014 Research and Markets ... Genomics and Proteomics Analytical Instruments Market 2014-2018" report ... Genomics is the study of the ... of the structure and functions of proteomes or sets ... and technology. Genomics involves the mapping of genes and ...
(Date:7/24/2014)... 24, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... notice on July 18, 2014 from the NYSE ... the CorMedix plan to regain compliance with continued ... the NYSE-MKT is continuing the Company,s listing and ...
(Date:7/24/2014)... 24, 2014  Neogen Corporation (Nasdaq: NEOG ... its potential revenue from new rodenticide research are premature. ... analysts on July 22, 2014, Neogen,s CEO commented about ... research. "It was my intent Tuesday at ... of a new type of rodenticide, but certainly not ...
(Date:7/24/2014)... Toronto, Canada (PRWEB) July 24, 2014 ... for Optimizing Dose Escalation in First in Human Studies” ... to make better go/no-go decisions. , With increasing R&D ... market, pharmaceutical companies need to maximize the knowledge collected ... go/no-go decisions and improve success in late stage development. ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
Cached News: